Spero Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Spero Therapeutics, Inc. To Contact The Firm

June 04, 2020 12:13 PM EDT | Source: Faruqi & Faruqi LLP

New York, New York--(Newsfile Corp. - June 4, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Spero Therapeutics, Inc. (NASDAQ: SPRO) ("Spero" or the "Company").

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6455/57218_f05fc3d2144acaa7_001full.jpg

Faruqi & Faruqi Logo

If you invested in Spero stock and would like to discuss your legal rights, click here: www.faruqilaw.com/SPRO. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/57218

info